I'd say a reasonable target for the '113 Phase 1 is the middle of 2012. You wouldn't enroll the Phase II portion until after the Phase I was completed.
But we should get preliminary efficacy data from the Phase I - maybe not the very first dose cohorts though.
ASH in November should be the next real pona news.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.